Ductal Carcinoma
In Situ
409
351. Finkelstein SD, Sayegh R, Thompson WR. Late recurrence of ductal
carcinoma
in situ
at the cutaneous end of surgical drainage following
total mastectomy.
Am Surg
1993;59:410–414.
352. Fisher DE, Schnitt SJ, Christian R, et al. Chest wall recurrence of
ductal carcinoma
in situ
of the breast after mastectomy.
Cancer
1993;71:3025–3028.
353. Srivastava A, Webster DJT. Isolated nipple recurrence seventeen years
after subcutaneous mastectomy for breast cancer—a case report.
Eur J
Surg Oncol
1987;13:459–461.
354. Price P, Sinnett HD, Gusterson B, et al. Duct carcinoma
in situ
: predic-
tors of local recurrence and progression in patients treated by surgery
alone.
Br J Cancer
1990;61:869–872.
355. Helvie MA, Wilson TE, Roubidoux MA, et al. Mammographic ap-
pearance of recurrent breast carcinoma in six patients with TRAM flap
breast reconstructions.
Radiology
1998;209:711–715.
356. Farrow JH. Current concepts in the detection and treatment of the
earliest of the early breast cancers.
Cancer
1970;25:458–479.
357. Joslyn SA. Ductal carcinoma
in situ
: trends in geographic, tempo-
ral, and demographic patterns of care and survival.
The Breast J
2006;12:20–27.
358. Kiaer W.
Relation of fibroadenomatosis (“Chronic Mastitis”) to cancer
of the breast
. Copenhagen: Ejnar Munksgaard, 1954:69.
359. Millis RR, Thynne GSJ.
In situ
intraduct carcinoma of the breast: a
long term follow-up study.
Br J Surg
1975;62:957–962.
360. Betsill WL Jr, Rosen PP, Lieberman PH, et al. Intraductal carci-
noma. Long-term follow-up after treatment by biopsy alone.
JAMA
1978;239:1863–1867.
361. Rosen PP, Braun DW Jr, Kinne DW. The clinical significance of pre-
invasive breast carcinoma.
Cancer
1980;46:919–925.
362. Harvey DG, Fechner RE. Atypical lobular and papillary lesions of the
breast: a follow-up study of 30 cases.
South Med J
1978;71:361–364.
363. Page DL, Dupont WD, Rogers LW, et al. Intraductal carcinoma of the
breast: follow-up after biopsy only.
Cancer
1982;49:751–758.
364. Page DL, Dupont WD, Rogers LW, et al. Continued local recurrence of
carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma
in situ
of the breast treated only by biopsy.
Cancer
1995;76:1197–1200.
365. Eusebi V, Foschini MP, Cook MG, et al. Long-term follow-up of
in
situ
carcinoma of the breast with special emphasis on clinging carci-
noma.
Diagn Pathol
1989;6:165–173.
366. Lagios MD, Margolin FR, Westdahl PR, et al. Mammographically de-
tected duct carcinoma
in situ
. Frequency of local recurrence following
tylectomy and prognostic effect of nuclear grade on local recurrence.
Cancer
1989;63:618–624.
367. Lagios MD. Evaluation of surrogate endpoint biomarkers for ductal
carcinoma
in situ
.
J Cell Biochem
1994;19(suppl.):186–188.
368. Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the Na-
tional Surgical Adjuvant Breast Project (Protocol 6). I. Intraductal
carcinoma (DCIS).
Cancer
1986;57:197–208.
369. Ottesen GL, Graversen HP, Blichert-Toft M, et al. Ductal carcinoma
in situ
of the female breast. Short-term results of a prospective nation-
wide study.
Am J Surg Pathol
1992;16:1183–1196.
370. Ringberg A, Andersson I, Aspegren K, et al. Breast carcinoma
in situ
in
167 women—incidence, mode of presentation, therapy and follow-up.
Eur J Surg Oncol
1991;17:466–476.
371. Arnesson L-G, Smeds S, Fagerberg G, et al. Follow-up of two treat-
ment modalities for ductal cancer
in situ
of the breast.
Br J Surg
1989;76:672–675.
372. Carpenter R, Boulter PS, Cooke T, et al. Management of screen
detected ductal carcinoma
in situ
of the female breast.
Br J Surg
1989;76:564–567.
373. Schwartz GF, Finkel GC, Garcia JC, et al. Subclinical ductal carcinoma
in situ
of the breast.
Cancer
1992;70:2468–2474.
374. Hetelekidis S, Collins L, Silver B, et al. Predictors of local recur-
rence following excision alone for ductal carcinoma
in situ
.
Cancer
1999;85:427–431.
375. Badve S, A’Hern RP, Ward AM, et al. Prediction of local recurrence
of ductal carcinoma
in situ
of the breast using five histological clas-
sifications: a comparative study with long follow-up.
Hum Pathol
1998;29:915–923.
376. Goonewardene S, Palazzo J, Cornfield D, et al. Prognostic significance
of necrosis in evaluating risk for recurrence of ductal carcinoma
in
situ
of the breast and progression to invasive carcinoma: survey
of 166 conservatively treated patients.
Am J Clin Pathol
1999;112:
531–532.
with ductal carcinoma
in situ
of the breast.
Breast Cancer Res Treat
2012;131:801–808.
325. Sänger N, Effenberger KE, Riethdorf S, et al. Disseminated tumor cells
in the bone marrow of patients with ductal carcinoma
in situ
.
Int J
Cancer
2011;129:2522–2526.
326. Pathology Working Group Breast Cancer Task Force. Standard-
ized management of breast cancer specimens.
Am J Clin Pathol
1973;60:789–798.
327. Goldstein NS, Lacerna M, Vicini F. Cancerization of lobules and
atypical ductal hyperplasia adjacent to ductal carcinoma
in situ
of the
breast.
Am J Clin Pathol
1998;110:357–367.
328. Hodi Z, Ellis IO, Elston CW, et al. Comparison of margin assessment
by radial and shave sections in wide local excision specimens for inva-
sive carcinoma of the breast.
Histopathology
2010;56:573–580.
329. Caughran JL, Vicini FA, Kestin LL, et al. Optimal use of re-excision
in patients diagnosed with early-stage breast cancer by excisional
biopsy treated with breast-conserving therapy.
Ann Surg Oncol
2009;16:3020–3027.
330. Guidroz JA, Larrieux G, Liao J, et al. Sampling of secondary margins
decreases the need for re-excision after partial mastectomy.
Surgery
2011;150:802–809.
331. Goldstein SN. Controversies in pathology in early-stage breast cancer.
Semin Radiat Oncol
2011;21:20–25.
332. Melstrom LG, Melstrom KA, Wang EC, et al. Ductal carcinoma
in
situ
: size and resection volume predict margin status.
Am J Clin Oncol
2010;33:438–442.
333. Coopey S, Smith BL, Hanson S, et al. The safety of multiple re-
excisions after lumpectomy for breast cancer.
Ann Surg Oncol
2011;18:3797–3801.
334. Nayak A, Bhuiya TA. Utility of cytokeratin 5/6 and high-molecular-
weight keratin in evaluation of cauterized surgical margins in ex-
cised specimens of breast ductal carcinoma
in situ
.
Ann Diagn Pathol
2011;15:243–249.
335. GoldhirschA, Ingle JN, Gelber RD, et al. Thresholds for therapies: high-
lights of the St Gallen International Expert Consensus on the primary
therapy of early breast cancer 2009.
Ann Oncol
2009;20:1319–1329.
336. Hughes LL, Wang M, Page DL, et al. Local excision alone without irra-
diation for ductal carcinoma
in situ
of the breast: a trial of the Eastern
Cooperative Oncology Group.
J Clin Oncol
2009;27:5319–5324.
337. Vincens E, Alves K, Lauratet B, et al. Margin status in ductal carci-
noma
in situ
of the breast (in French).
Bull Cancer
2008;95:1155–1159.
338. Dunne C, Burke JP, Morrow M, et al. Effect of margin status on local
recurrence after breast conservation and radiation therapy for ductal
carcinoma
in situ
.
J Clin Oncol
2009;27:1615–1620.
339. Mansel RE. Ductal carcinoma
in situ
: surgery and radiotherapy.
Breast
2003;12:447–450.
340. Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of inva-
sive ipsilateral breast tumor recurrences after lumpectomy in NSABP
B-17 and B-24 randomized clinical trials for DCIS.
J Natl Cancer Inst
2011;103:478–488.
341. Morrow M, Harris JR, Schnitt SJ. Surgical margins in lumpectomy for
breast cancer—bigger is not better.
N Engl J Med
2012;367:79–82.
342. Hughes JH, Mason MC, Gray RJ, et al. A multi-site validation trial
of radioactive seed localization as an alternative to wire localization.
Breast J
2008;14:153–157.
343. Alderliesten T, Loo CE, Pengel KE, et al. Radioactive seed localization
of breast lesions: an adequate localization method without seed migra-
tion.
Breast J
2011;17:594–601.
344. Thill M, Röder K, Diedrich K, et al. Intraoperative assessment of surgi-
cal margins during breast conserving surgery of ductal carcinoma
in
situ
by use of radiofrequency spectroscopy.
Breast
2011;20:579–580.
345. Kinne DW, Petrek JA, Osborne MP, et al. Breast carcinoma
in situ
.
Arch Surg
1989;124:33–36.
346. Sunshine JA, Moseley HS, Fletcher WS, et al. Breast carcinoma
in situ
.
A retrospective review of 112 cases with minimum 10 year follow-up.
Am J Surg
1985;150:44–51.
347. Carter D, Smith AL. Carcinoma
in situ
of the breast.
Cancer
1977;40:1189–1193.
348. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treat-
mentofductalcarcinoma
insitu
:ameta-analysis.
Cancer
1999;85:616–628.
349. Clark L, Ritter E, Glazebrook K, et al. Recurrent ductal carcinoma
in
situ
after total mastectomy.
J Surg Oncol
1999;71:182–185.
350. Montgomery RC, Fowble BL, Goldstein LJ, et al. Local recurrence after
mastectomy for ductal carcinoma
in situ
.
Breast J
1998;4:430–436.
